Ultima Genomics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
308
- Latest Deal Type
-
Later Stage VC
- Investors
-
17
Ultima Genomics General Information
Description
Developer of genome-scale sequencing technology designed to offer analytical services to enterprises. The company uses an open substrate to create a massive, low-cost reaction surface that delivers many billions of reads while avoiding costly flow cells and complicated fluidics, and uses specialized sequencing hardware along with machine learning to deliver reproducible and accurate results, enabling clients to get genomics reports at scale with speed and efficiency and to drive down the costs of sequencing.
Contact Information
Website
www.ultimagenomics.comCorporate Office
- 4209 Technology Drive
- Fremont, CA 94538
- United States
Corporate Office
- 4209 Technology Drive
- Fremont, CA 94538
- United States
Ultima Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | Completed | Generating Revenue | ||||
| 7. Later Stage VC (Series E) | 31-May-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 22-Dec-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | Completed | Generating Revenue | ||||
| 4. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A) | 28-Dec-2017 | $31M | $43.8M | Completed | Generating Revenue | |
| 1. Seed Round | $12.8M | $12.8M | Completed | Generating Revenue |
Ultima Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series E-1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A | 9,759,520 | $0.000100 | $3.24 | $3.24 | 1x | $3.24 | 13.48% | |
| Seed | 7,157,895 | $0.000100 | $1.78 | $1.78 | 1x | $1.78 | 9.89% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ultima Genomics Comparisons
Industry
Financing
Details
Ultima Genomics Competitors (22)
One of Ultima Genomics’s 22 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Adaptyv | Venture Capital-Backed | Lausanne, Switzerland | ||||
| DNAe | Formerly VC-backed | London, United Kingdom | ||||
| ATUM (Biotechnology) | Formerly VC-backed | Newark, CA | ||||
| Diagenode | Formerly VC-backed | Seraing, Belgium |
Ultima Genomics Patents
Ultima Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026217964-A1 | Systems and methods for high throughput sequencing | Pending | 11-Apr-2025 | ||
| WO-2026178174-A2 | Adapter sequences and methods of use thereof | Pending | 18-Feb-2025 | ||
| US-20250377524-A1 | Novel illumination and background rejection for enhanced resolution imaging | Pending | 07-Jun-2024 | ||
| WO-2025213126-A2 | Systems and methods for spatial reference sequencing | Pending | 05-Apr-2024 | ||
| WO-2025213126-A3 | Systems and methods for spatial reference sequencing | Pending | 05-Apr-2024 | C12Q1/6874 |
Ultima Genomics Signals
Ultima Genomics Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| aMoon Fund | Venture Capital | Minority | ||
| Andreessen Horowitz | Venture Capital | Minority | ||
| Bow River Capital | PE/Buyout | Minority | ||
| D1 Capital Partners | Hedge Fund | Minority | ||
| Founders Fund | Venture Capital | Minority |
Ultima Genomics FAQs
-
When was Ultima Genomics founded?
Ultima Genomics was founded in 2016.
-
Where is Ultima Genomics headquartered?
Ultima Genomics is headquartered in Fremont, CA.
-
What is the size of Ultima Genomics?
Ultima Genomics has 308 total employees.
-
What industry is Ultima Genomics in?
Ultima Genomics’s primary industry is Discovery Tools (Healthcare).
-
Is Ultima Genomics a private or public company?
Ultima Genomics is a Private company.
-
What is Ultima Genomics’s current revenue?
The current revenue for Ultima Genomics is .
-
How much funding has Ultima Genomics raised over time?
Ultima Genomics has raised $600M.
-
Who are Ultima Genomics’s investors?
aMoon Fund, Andreessen Horowitz, Bow River Capital, D1 Capital Partners, and Founders Fund are 5 of 17 investors who have invested in Ultima Genomics.
-
Who are Ultima Genomics’s competitors?
Illumina, Adaptyv, DNAe, ATUM (Biotechnology), and Diagenode are some of the 22 competitors of Ultima Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process